Emma S. McBryde
- Modeling and Simulation top 0.2%
- COVID-19 epidemiological studies 42
- Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology 68
- Antimicrobial Resistance in Staphylococcus 14
- Epidemiology top 1%
- Pneumonia and Respiratory Infections 36
- Pneumocystis jirovecii pneumonia detection and treatment 24
- Influenza Virus Research Studies 19
- Mycobacterium research and diagnosis 17
- Hepatology top 2%
-
- Diagnosis and treatment of tuberculosis 16
Emma S. McBryde
188 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Modeling and Simulation 1.0k
- Infectious Diseases 2.5k
- Applied Microbiology and Biotechnology 167
- Epidemiology 2.4k
- Hepatology 477
Countries citing papers authored by Emma S. McBryde
This map shows the geographic impact of Emma S. McBryde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma S. McBryde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma S. McBryde more than expected).
Fields of papers citing papers by Emma S. McBryde
This network shows the impact of papers produced by Emma S. McBryde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma S. McBryde. The network helps show where Emma S. McBryde may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emma S. McBryde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 20 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 19 | |
| 11 | 2020 | 21 | |
| 12 | 2020 | 28 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 50 | |
| 15 | 2018 | 37 | |
| 16 | 2018 | 13 | |
| 17 | 2017 | 17 | |
| 18 | 2017 | 26 | |
| 19 | 2016 | 115 | |
| 20 | 2015 | 47 |
About Emma S. McBryde
Emma S. McBryde is a scholar working on Modeling and Simulation, Infectious Diseases and Epidemiology, having authored 194 papers that have together received 5.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (68 papers), COVID-19 epidemiological studies (42 papers), Pneumonia and Respiratory Infections (36 papers), Pneumocystis jirovecii pneumonia detection and treatment (24 papers), Influenza Virus Research Studies (19 papers), Mycobacterium research and diagnosis (17 papers), Diagnosis and treatment of tuberculosis (16 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). The work is most often cited by research in Modeling and Simulation (1.0k citations), Infectious Diseases (2.5k citations) and Applied Microbiology and Biotechnology (167 citations). Emma S. McBryde has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include James M. Trauer, Damon P. Eisen, Justin T. Denholm, Adeshina I. Adekunle, Oyelola A. Adegboye, Anton Pak, Michael T. Meehan, Margaret Hellard, Md Abdul Kuddus and Liz Tynan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.